Ann: 2023 Annual Report, page-4

One person who doesn't seem to share my hopes for the company is the founder Dr Matthew Myntti!

At listing he held 20 657 000 shares.
By September 2021, he had sold 6 589 000 of these at an average price of $1.31
By November 2022, he had sold another 1 293 000 of these at an average price of $1.05
By March 2023, he had sold another 2 323 886 of these shares at an average price of 68c
As at 4 March 2024, he has sold another 6 279 279 of these shares.

He only has 4,17 million shares left.

Q1 numbers will be interesting.
I am pretty confident that they will achieve their main target of being cashflow positive before the end of the financial year and that should be the catalyst for a big rerate of this share.